Cellular Biomedicine Group Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Palo Alto United States (2009)

Organization Overview

First Clinical Trial
2012
NCT01828762
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Cellular Biomedicine Group Ltd.